Activating somatic and germline TERT promoter variants in myeloid malignancies

Leukemia. 2021 Jan;35(1):274-278. doi: 10.1038/s41375-020-0837-6. Epub 2020 May 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Genetic Association Studies* / methods
  • Genetic Predisposition to Disease*
  • Genotype
  • Germ-Line Mutation*
  • Humans
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / genetics*
  • Mutation*
  • Promoter Regions, Genetic*
  • Telomerase / genetics*

Substances

  • TERT protein, human
  • Telomerase